Hiroaki Matsuda

Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5).

Takenori Yamaguchi, N. Tanahashi, Hideto Awano, 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Baseline Characterization of Japanese Peripheral Arterial Disease Patients　- Analysis of Surveillance of Cardiovascular Events in Antiplatelet-Treated Arteriosclerosis Obliterans Patients in Japan (SEASON).

M. Fujita, H. Naritomi, T. Miyata, 2016, Circulation journal : official journal of the Japanese Circulation Society.

Evaluation of Risk Factors for Limb-Specific Peripheral Vascular Events in Patients With Peripheral Artery Disease: A Post Hoc Analysis of the SEASON Prospective Observational Study

M. Fujita, H. Naritomi, T. Miyata, 2018, Angiology.

Postmarketing surveillance of telaprevir‐based triple therapy for chronic hepatitis C in Japan

A. Okada, Hiroaki Matsuda, I. Umebayashi, 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

Conductive Hearing Loss Produces a Reversible Binaural Hearing Impairment

Andrew J. King, David R. Moore, J. Hine, 1999, The Journal of Neuroscience.

Two-Year Follow-Up of Vascular Events in Peripheral Arterial Disease Treated With Antiplatelet Agents: A Prospective Observational Multicenter Cohort Study (SEASON)

M. Fujita, H. Naritomi, T. Miyata, 2017, Scientific Reports.

Outcome of Acute Ischemic Stroke after the Treatment with Edaravone and 0.6 Mg/Kg Alteplase in Japanese Patients with Diabetes.

Takenori Yamaguchi, N. Tanahashi, Hideto Awano, 2018, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.